Olopatadine Hydrochloride Ophthalmic Solution
FDA Label NDC 68083-231

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Gland Pharma Limited for the product Olopatadine Hydrochloride Ophthalmic Solution (NDC 68083-231). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

BULK LABEL

NDC 68083-231-85

Olopatadine Hydrochloride Ophthalmic Solution, USP, 0.2%

Quantity- 1000 - 2.5 mL Bottles

Batch No. :

Mfg. Date :

Repack

Before :

Expiration Date : MM/YYYY

Store at 2°-25°C (36°-77°F)

CAUTION: For Manufacturing, processing or repackaging only.

Manufactured by :

Gland Pharma Limited 

D.P. Pally, Hyderabad - 500043, INDIA

Code: AP/DRUGS/103/97

Olopatadine-spl-shipper (Olopatadine Spl Shipper)

Olopatadine-spl-shipper (Olopatadine Spl Shipper)


* Please review the disclaimer below.